» Articles » PMID: 30078514

Analysis of the Global Burden of Disease Study Highlights the Global, Regional, and National Trends of Chronic Kidney Disease Epidemiology from 1990 to 2016

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2018 Aug 7
PMID 30078514
Citations 398
Authors
Affiliations
Soon will be listed here.
Abstract

The last quarter century witnessed significant population growth, aging, and major changes in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) epidemiology. Here, we used the Global Burden of Disease study data and methodologies to describe the change in burden of CKD from 1990 to 2016 involving incidence, prevalence, death, and disability-adjusted-life-years (DALYs). Globally, the incidence of CKD increased by 89% to 21,328,972 (uncertainty interval 19,100,079- 23,599,380), prevalence increased by 87% to 275,929,799 (uncertainty interval 252,442,316-300,414,224), death due to CKD increased by 98% to 1,186,561 (uncertainty interval 1,150,743-1,236,564), and DALYs increased by 62% to 35,032,384 (uncertainty interval 32,622,073-37,954,350). Measures of burden varied substantially by level of development and geography. Decomposition analyses showed that the increase in CKD DALYs was driven by population growth and aging. Globally and in most Global Burden of Disease study regions, age-standardized DALY rates decreased, except in High-income North America, Central Latin America, Oceania, Southern Sub-Saharan Africa, and Central Asia, where the increased burden of CKD due to diabetes and to a lesser extent CKD due to hypertension and other causes outpaced burden expected by demographic expansion. More of the CKD burden (63%) was in low and lower-middle-income countries. There was an inverse relationship between age-standardized CKD DALY rate and health care access and quality of care. Frontier analyses showed significant opportunities for improvement at all levels of the development spectrum. Thus, the global toll of CKD is significant, rising, and unevenly distributed; it is primarily driven by demographic expansion and in some regions a significant tide of diabetes. Opportunities exist to reduce CKD burden at all levels of development.

Citing Articles

Regional insights into the relationship between metabolic associated steatotic liver disease and chronic kidney disease: a socioeconomic perspective on disease correlation.

Bai J, Zhang L, Zhang M, Hao Y, Yi Z, Zhou Y BMC Public Health. 2025; 25(1):993.

PMID: 40082841 PMC: 11907813. DOI: 10.1186/s12889-025-22188-3.


Global burden of chronic kidney disease due to diabetes mellitus, 1990-2021, and projections to 2050.

Ma X, Liu R, Xi X, Zhuo H, Gu Y Front Endocrinol (Lausanne). 2025; 16:1513008.

PMID: 40060381 PMC: 11885120. DOI: 10.3389/fendo.2025.1513008.


Global, regional and national burden of liver cancer 1990-2021: a systematic analysis of the global burden of disease study 2021.

Jiang Z, Zeng G, Dai H, Bian Y, Wang L, Cao W BMC Public Health. 2025; 25(1):931.

PMID: 40057711 PMC: 11890516. DOI: 10.1186/s12889-025-22026-6.


Global, regional, and national epidemiology of osteoarthritis in working-age individuals: insights from the global burden of disease study 1990-2021.

Ma W, Chen H, Yuan Q, Chen X, Li H Sci Rep. 2025; 15(1):7907.

PMID: 40050342 PMC: 11885640. DOI: 10.1038/s41598-025-91783-6.


Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021.

Su X, Tao Y, Chen F, Han X, Xue L Sci Rep. 2025; 15(1):7655.

PMID: 40038504 PMC: 11880295. DOI: 10.1038/s41598-025-92033-5.